Art

J-GLOBAL ID：201702275461564261   Reference number：17A0136219

Serotonin 5-HT2B receptor antagonism is fundamental for protecting PC12 cells exposed to hydrogen peroxide

セロトニン5-HT2B受容体拮抗作用は過酸化水素に曝露したPC12細胞を保護する基本である

Author (12)： Takayanagi Takeshi (Division of Endocrinology and Metabolism, Department of Internal Medicine, Fujita Health University School of Medicine) ,  Kaneko S. Yoko (Department of Physiology, Fujita Health University School of Medicine) ,  Nagasaki Hiroshi (Department of Physiology, Fujita Health University School of Medicine) ,  Kodani Yu ,  Nakashima Akira ,  Mori Keiji (Department of Health Sciences, Kinjo University) ,  Suzuki Atsushi (Division of Endocrinology and Metabolism, Department of Internal Medicine, Fujita Health University School of Medicine) ,  Itoh Mitsuyasu (Division of Endocrinology and Metabolism, Department of Internal Medicine, Fujita Health University School of Medicine) ,  Kondo Kazunao (Department of Pharmacology, Fujita Health University School of Medicine) ,  Nagatsu Toshiharu (Department of Pharmacology, Fujita Health University School of Medicine) ,  Ota Miyuki (Department of Psychiatry, Tosei General Hospital) ,  Ota Akira (Department of Physiology, Fujita Health University School of Medicine)
Material： Fujita Medical Journal (Web)  (Fujita Med J (Web))
Volume： 1  Issue： 1  Page： 1-5(J-STAGE)  Publication year： 2015 
JST Material Number： U0775A  ISSN： 2189-7255  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： PC12 cell ,...
Semi thesaurus term： *Receptor, Serotonin, 5-HT2B ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0136219&from=J-GLOBAL&jstjournalNo=U0775A") }}

Author keywords (5)： hydrogen peroxide ,  PC12 cells ,  aripiprazole ,  serotonin 5-HT2B-receptor ,  dopamine D1-receptor

JST classification (1)： Basic research of psychotropic drugs  (GW03100Y)

Substance index (1)： Aripiprazole

Reference (36)：

• 1. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 2002;302:381-9.
• 2. Jordan S, Koprivica V, Chen R, Tottori K, Kikuchi T, Altar CA. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol 2002;441:137-40.
• 3. Keltner NL, Johnson V. Biological perspectives. Aripiprazole: a third generation of antipsychotics begins? Perspect Psychiatr Care 2002;38:157-9.
• 4. Roth BL, Ciaranello RD, Meltzer HY. Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. J Pharmacol Exp Ther 1992;260:1361-5.
• 5. Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Roth BL, Mailman R. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 2003;28:1400-11.

Terms in the title (6)： セロトニン ,  5-HT2B受容体 ,  拮抗作用 ,  過酸化水素 ,  曝露 ,  PC12細胞